Argentina

Lupin has added two ADHD drugs to its Canadian portfolio, while also signing multiple branded deals in other global markets.

Number of regulators formally agreeing to work toward creating Latin American regulator is growing.

The number of regulators formally agreeing to work towards creating a Latin American regulator is growing.

Medicines regulators from Mexico, Colombia and Cuba have pledged to create a new agency for medicines and medical devices of Latin America and the Caribbean.

Laboratorio Elea has struck a deal with Nichi-Iko Pharmaceutical to market the Japanese firm’s infliximab biosimilar in Argentina.

The Russian Direct Investment Fund says it has 20 technology transfer and production agreements in place in 13 countries across the world.

While the US and EU regulators seem less than keen on the data package offered to date on COVID-19 Vaccine AstraZeneca, Latin American countries are moving quickly to follow the UK in backing the cost-effective and more-easily deliverable option.

The latest round-up from the Pink Sheet of developments relating to COVID-19.

Argentina’s off-patent industry association, CILFA, has joined global body the IGBA as an associate member.

Henlius has struck a deal with Mabxience to market its HLX02 trastuzumab biosimilar in Argentina, Uruguay and Paraguay.